Amr El-Shafei, MD
Cardiovascular Disease · Rogers, ARNPI 1144399718
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Boston Scientific at 36.2% of the total. Reporting peaked in 2022 at $7,567 and has fallen 77.9% since, to $1,671 in 2025.
Across 435 payments — averaging $52.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Medtronic$7K
- Penumbra, Inc.$2K
- Abbott$2K
- Philips North America LLC$928
- W. L. Gore & Associates, Inc.$560
- plus $3K from 30 others
Across 41 payments — averaging $1430.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$33K
- Boston Scientific$25K
What the payments were for
- Consulting fees$5,45024%
- Travel & lodging$6,90530%
- Food & beverage$10,30245%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 58 | $8,240 |
| Medtronic(2 entities) | 173 | $6,653 |
| Penumbra, Inc. | 7 | $2,023 |
| Abbott | 80 | $1,518 |
| Philips North America LLC | 11 | $928 |
| W. L. Gore & Associates, Inc. | 1 | $560 |
| Edwards Lifesciences | 4 | $436 |
| Inari Medical, Inc. | 16 | $398 |
| Amgen | 6 | $193 |
| Pfizer | 13 | $184 |
| Silk Road Medical, Inc. | 1 | $180 |
| Abiomed | 2 | $178 |
| Novartis | 10 | $151 |
| Biotronik Inc. | 2 | $149 |
| Merck | 9 | $138 |
| Bard Peripheral Vascular, Inc. | 4 | $95 |
| Baxter Healthcare | 4 | $83 |
| Amarin Pharma, Inc. | 4 | $81 |
| Heartflow, Inc. | 1 | $64 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $60 |
| AstraZeneca | 4 | $52 |
| Cardiovascular Systems Inc. | 2 | $49 |
| Cardiva Medical, Inc. | 3 | $47 |
| Elutia, Inc. | 5 | $47 |
| Endologix LLC | 1 | $40 |
| Novo Nordisk | 1 | $32 |
| Atricure, Inc. | 1 | $31 |
| Cordis US CORP. | 1 | $24 |
| Cook Medical LLC | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Boehringer Ingelheim | 1 | $11 |
| EMD Serono, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL VASCULAR INTERVENTION$6,011
- Indigo System$1,866
- Micra$1,072
- ANGIOJET$737
- NeoView$611
- VIABAHN Endoprosthesis$560
- SelectSecure$279
- Watchman$215
- ENROUTE Transcarotid Neuroprotection System$180
- ENROUTE Transcarotid Stent$180
- ENROUTE .014 Guidewire$180
- ENHANCE Transcarotid Peripheral Access Kit$180
- Ranger$146
- (9520) IGT Devices Undivided$145
- Impella$141
- FLOWTRIEVER CATHETER, S$135
- CT THROMBECTOMY SYSTEM KIT$135
- Repatha$128
- Edwards SAPIEN 3 Transcatheter Heart Valve$125
How this compares
$22,737 in reported general payments places this provider in the 85th percentile of 130 cardiovascular disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 725 | $700,642 |
| XareltoRivaroxaban | 375 | $370,587 |
| EntrestoSacubitril/Valsartan | 250 | $218,390 |
| Repatha SureclickEvolocumab | 182 | $124,904 |
| BrilintaTicagrelor | 92 | $62,284 |
| JardianceEmpagliflozin | 59 | $57,749 |
| FarxigaDapagliflozin Propanediol | 34 | $26,632 |
| VerquvoVericiguat | 29 | $19,352 |
| Repatha SyringeEvolocumab | 24 | $16,245 |
| Praluent PenAlirocumab | 22 | $14,112 |
| ClopidogrelClopidogrel Bisulfate | 1,199 | $11,417 |
| Metoprolol Succinate | 941 | $9,773 |
| Dofetilide | 31 | $5,885 |
| VascepaIcosapent Ethyl | 13 | $5,883 |
| Ranolazine ErRanolazine | 63 | $5,081 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $184 | $700,642725 claims |
| Johnson & JohnsonXarelto | $14 | $370,587375 claims |
| NovartisEntresto | $151 | $218,390250 claims |
| AstraZenecaBrilinta, Farxiga | $52 | $88,916126 claims |
| Boehringer IngelheimJardiance | $11 | $57,74959 claims |
| MerckVerquvo | $138 | $19,35229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 130 cardiovascular disease providers in Arkansas.
Other cardiovascular disease in Rogers
- Kiran KurichetyRogers$9K
- Philip RileyRogers$8K
- Lance WeathersRogers$8K
- Larry WeathersRogers$6K
- Robert StuppyRogers$5K
- Ian CawichLittle Rock$294K
- Barry TedderJonesboro$130K
- Harvinder DodEl Dorado$126K
- William RollefsonLittle Rock$74K
- Andre PaixaoLittle Rock$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.